Articles by Theresa Tamkins

The relationship between business -- in this case pharma and biotech -- and the media is a tangled one. Companies hope to get the attention of major media outlets, but only if it?s the right kind. Reporters, on the other hand, are digging to get the real story behind the press release, and their ultimate loyalty is to their readers.And a disgruntled lot of readers they are, at least in terms of the pharmaceutical industry, according to a panel of experts who spoke Monday at the Biotechnology

Paul Carter was a professor at the University of Wisconsin before jumping to his current position as director of global agronomy sciences at Pioneer Hi-Bred International, in Johnston, Iowa.

Postdocs in Canada and Europe are a lot like their compatriots in the United States.

Canada has been putting the pieces of the puzzle together in recent years, and a pretty picture is emerging for scientists. A new focus on innovative programs and increased funding for scientists suggests that it's no fluke that for the first time, five Canadian universities are in the top 10 of The Scientist's 2004 survey of the Best Places to Work in Academia.Since the late 1990s, the research environment in Canada has witnessed "a virtual revolution," says Bruce McManus, a professor of pathol

New Jersey put it in the budget. California may put it on a ballot. The two states announced in recent weeks that they are looking to give stem cell research a cash infusion.A group in California is trying to get a bond initiative on the ballot in November that would provide $3 billion (US)-roughly $300 million per year for 10 years-to support stem cell research. And if the New Jersey budget proposal passes, it would provide $6.5 million in the first year, and an additional $50 million in public

If budget is passed, New Jersey will be first US state to invest in stem cell research

South Korean team demonstrates cloning efficiency for humans similar to pigs, cattle

Scientists praise act that promotes stem cell research, criminalizes reproductive cloning

Last-minute change to cut delay in talks from 2 years to 1 year angers UK

US-led group may push total ban, despite earlier vote to delay a decision for 2 years

Choice between total and partial bans on human embryo cloning put off for 2 years